XML 17 R7.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities:    
Net loss $ (2,842) $ (1,634)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Loss from discontinued operations 0 24
Net loss from securities transactions 2,777 314
Purchases of securities (1,480) (3,885)
Proceeds from sales of securities 3,756 2,133
Payments to cover securities sold, not yet purchased (2,291) (451)
Proceeds from securities sold, not yet purchased 1,547 142
Changes in receivables and payables relating to securities transactions 1,080 609
Gain on disposition of assets, net (5) (256)
Depreciation and amortization 379 389
Deferred taxes (59) (84)
Other, net 79 (1)
Changes in unrealized gains/losses on derivative contracts (2,309) 800
Changes in other operating assets and liabilities 92 32
Net cash provided by (used in) operating activities 724 (1,868)
Cash flows from investing activities:    
Capital expenditures (155) (195)
Turnaround expenditures (158) (24)
Acquisition of businesses, net of cash acquired (2) (52)
Purchases of investments (317) (50)
Proceeds from sale of investments 55 458
Proceeds from disposition of businesses and assets 23 491
Other, net 3 3
Net cash (used in) provided by investing activities (551) 631
Cash flows from financing activities:    
Investment segment contributions from non-controlling interests 1 220
Partnership contributions 61 35
Partnership distributions (493) (83)
Purchase of additional interests in consolidated subsidiaries 0 (241)
Dividends and distributions to non-controlling interests in subsidiaries (36) (90)
Proceeds from Holding Company senior unsecured notes 866 1,757
Repayments of Holding Company senior unsecured notes (1,350) (1,700)
Proceeds from subsidiary borrowings 1,644 565
Repayments of subsidiary borrowings (1,244) (597)
Other, net (17) (3)
Net cash used in financing activities (568) (137)
Effect of exchange rate changes on cash and cash equivalents and restricted cash and restricted cash equivalents (1) (2)
Add back change in cash and restricted cash of assets held for sale 0 (83)
Net decrease in cash and cash equivalents and restricted cash and restricted cash equivalents (396) (1,459)
Cash and cash equivalents and restricted cash and restricted cash equivalents, beginning of period 4,945 5,338
Cash and cash equivalents and restricted cash and restricted cash equivalents, end of period 4,549 3,879
Icahn Enterprises Holdings    
Cash flows from operating activities:    
Net loss (2,842) (1,633)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Loss from discontinued operations 0 24
Net loss from securities transactions 2,777 314
Purchases of securities (1,480) (3,885)
Proceeds from sales of securities 3,756 2,133
Payments to cover securities sold, not yet purchased (2,291) (451)
Proceeds from securities sold, not yet purchased 1,547 142
Changes in receivables and payables relating to securities transactions 1,080 609
Gain on disposition of assets, net (5) (256)
Depreciation and amortization 379 389
Deferred taxes (59) (84)
Other, net 79 (2)
Changes in unrealized gains/losses on derivative contracts (2,309) 800
Changes in other operating assets and liabilities 92 32
Net cash provided by (used in) operating activities 724 (1,868)
Cash flows from investing activities:    
Capital expenditures (155) (195)
Turnaround expenditures (158) (24)
Acquisition of businesses, net of cash acquired (2) (52)
Purchases of investments (317) (50)
Proceeds from sale of investments 55 458
Proceeds from disposition of businesses and assets 23 491
Other, net 3 3
Net cash (used in) provided by investing activities (551) 631
Cash flows from financing activities:    
Investment segment contributions from non-controlling interests 1 220
Partnership contributions 61 35
Partnership distributions (493) (83)
Purchase of additional interests in consolidated subsidiaries 0 (241)
Dividends and distributions to non-controlling interests in subsidiaries (36) (90)
Proceeds from Holding Company senior unsecured notes 866 1,757
Repayments of Holding Company senior unsecured notes (1,350) (1,700)
Proceeds from subsidiary borrowings 1,644 565
Repayments of subsidiary borrowings (1,244) (597)
Other, net (17) (3)
Net cash used in financing activities (568) (137)
Effect of exchange rate changes on cash and cash equivalents and restricted cash and restricted cash equivalents (1) (2)
Add back change in cash and restricted cash of assets held for sale 0 (83)
Net decrease in cash and cash equivalents and restricted cash and restricted cash equivalents (396) (1,459)
Cash and cash equivalents and restricted cash and restricted cash equivalents, beginning of period 4,945 5,338
Cash and cash equivalents and restricted cash and restricted cash equivalents, end of period $ 4,549 $ 3,879